Partnerships · healthcare · LATAMJul 20269 min read348 words

Partnerships and co-selling for startups under 20 people for healthcare and life sciences in Latin America

How under-20-person startups get partnerships and co-selling live without hiring — the specific version of the playbook designed for constraint. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Latin America.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install partnerships and co-selling has to be shaped to that reality from day one.

The under-20-person version of partnerships and co-selling is not a diluted enterprise playbook. It is using another company's distribution to reach buyers you cannot cost-effectively reach yourself with different constraints: no headcount, no politics, and no time to be wrong for long.

Own it personally as a founder or lean-in operator for the first quarter. Hiring a specialist too early replaces context with process.

Pick one channel, one trigger, one message. Two of anything at this stage is too many and none of them will work.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Partnerships and co-selling is only useful here when it is pointed at both constraints at once.

Instrument sourced and influenced pipeline from partners in a spreadsheet if you have to. Legibility beats sophistication under 20 people.

The startup-specific trap is signing MOUs no one operationalises, usually because a well-meaning advisor points at what worked at their $50m company. Ignore.

Budget rules: whatever you spend on tools, spend the same on the person operating them. Under-tooling is fine; under-humaning is not.

A working partnerships and co-selling function at 15 people is a genuine moat — most competitors of that size do not have one, and the discipline carries forward as the company grows.

Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing partnerships and co-selling deliberately for this market rather than importing a playbook designed for somewhere else.

B2B partnershipsco-sellingchannelstartup B2B partnershipsB2B partnerships for early stageB2B partnerships for healthcare and life sciencesB2B partnerships in Latin Americahealthcare and life sciences growth in Latin America

Frequently asked questions

Partnerships · healthcare · LATAM — answered

Does partnerships and co-selling work for healthcare and life sciences in Latin America?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms. The healthcare teams that install this get past procurement instead of dying in it.
Can a five-person team run partnerships and co-selling?
Yes, if the founder owns it. The lower headcount, the more concentrated the ownership.
What is the smallest useful partnerships and co-selling setup?
One channel, one trigger, one message, and a spreadsheet tracking sourced and influenced pipeline from partners.
Should we hire a specialist for partnerships and co-selling?
Not in the first quarter. Own it personally until the model is proven.
What common advice should startups ignore?
Anything derived from a company more than 10x larger. Constraints differ.
What is the LATAM-specific pitfall when running partnerships and co-selling for healthcare?
Importing a playbook that was built for another market. In Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms — the install has to reflect that.

Growth Broker editorial

Filed under partnerships · healthcare · latam

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call